ClinicalTrials.Veeva

Find clinical trials for Non-Small-Cell Lung Cancer in New Haven, CT

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Non-Small-Cell Lung Carcinoma
Lung Cancer
Cancer
Carcinoma
Squamous Cell Carcinoma of Head and Neck
Triple Negative Breast Cancer
Colorectal Cancer

Non-Small-Cell Lung Cancer trials near New Haven, CT, USA:

Treating Early-stage Non-Small Cell Lung Cancer With Durvalumab and Radiation Therapy

body radiation (SBRT) is a more effective treatment for early-stage non-small cell lung cancer (NSCLC) t...

Enrolling
Non-small Cell Lung Cancer Stage II
Non-small Cell Lung Cancer Stage IIIA
Radiation: Stereotactic Body Radiation Therapy
Drug: Durvalumab

Phase 2

Memorial Sloan Kettering Cancer Center (MSK)
Memorial Sloan Kettering Cancer Center (MSK)

Hartford, Connecticut, United States and 8 other locations

This is a study of the efficacy, pharmacokinetics, and safety of DS-1062a in participants with advanced or metastatic non-small cell...

Active, not recruiting
Non-small Cell Lung Cancer
Drug: DS-1062a

Phase 2

Daiichi Sankyo
Daiichi Sankyo

Port Jefferson, New York, United States and 83 other locations

in participants with no prior therapy for advanced or metastatic non-squamous non-small cell lung cancer...

Enrolling
Metastatic Non Small Cell Lung Cancer
Drug: Cisplatin
Drug: Datopotamab Deruxtecan

Phase 3

Daiichi Sankyo
Daiichi Sankyo

Port Jefferson Station, New York, United States and 139 other locations

PDCT in participants with previously untreated Stage IV or recurrent non-small cell lung cancer (NSCLC)....

Active, not recruiting
Metastatic Non-small Cell Lung Cancer
Non-small Cell Lung Cancer
Drug: Pemetrexed
Drug: Paclitaxel

Phase 2

Bristol-Myers Squibb (BMS)
Bristol-Myers Squibb (BMS)

New Haven, Connecticut, United States and 126 other locations

This is a Phase III, randomized, double-blind, placebo-controlled, multi-center international study assessing the activity of durvalumab and chemothe...

Active, not recruiting
Non-Small Cell Lung Cancer
Drug: Paclitaxel
Procedure: Surgery

Phase 3

AstraZeneca
AstraZeneca

Shirley, New York, United States and 230 other locations

A study to assess the Effects of MEDI4736 (Durvalumab) in Patients With Locally Advanced or Metastatic Non Small Cell Lung...

Active, not recruiting
Non-Small Cell Lung Cancer
Drug: MEDI4736

Phase 2

AstraZeneca
AstraZeneca

New Haven, Connecticut, United States and 137 other locations

and radiation therapy in treating patients with stage II-IIIB non-small cell lung cancer. Monoclonal ant...

Active, not recruiting
Stage IIIA Non-Small Cell Lung Cancer
Stage IIIB Non-Small Cell Lung Cancer
Other: Laboratory Biomarker Analysis
Drug: Carboplatin

Phase 1

Rutgers The State University of New Jersey
Rutgers The State University of New Jersey

New Haven, Connecticut, United States and 2 other locations

and osimertinib in subjects with locally advanced or metastatic non-small cell lung cancer (NSCLC) with ...

Enrolling
Non-Small Cell Lung Cancer (NSCLC)
Drug: Osimertinib
Drug: HER3-DXd

Phase 1

Daiichi Sankyo
Daiichi Sankyo

New Haven, Connecticut, United States and 30 other locations

This is a pilot study using [18F]F AraG PET imaging to evaluate the immunological response to checkpoint inhibitor therapy (CkIT) in patients with ad...

Enrolling
Non Small Cell Lung Cancer
Drug: [18F]F AraG

Phase 2

CellSight Technologies

Stony Brook, New York, United States and 2 other locations

(MRD) is an effective treatment approach for locally advanced non-small cell lung cancer (LA-NSCLC). The...

Enrolling
Non-Small Cell Lung Cancer
Drug: Durvalumab
Drug: Sotorasib

Phase 2

Memorial Sloan Kettering Cancer Center (MSK)
Memorial Sloan Kettering Cancer Center (MSK)

Commack, New York, United States and 6 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems